Sarepta Therapeutics Competitors
| Ticker | Name | Consensus | Stock Rating | Price | Price Target | Upside/Downside | Analysts | Market Cap |
|---|---|---|---|---|---|---|---|---|
| PFE | Pfizer | Outperform |
2
|
$28.64 | $32.87 | 6.49% | 6 | $162.29B |
| SAN | Sanofi | Outperform |
16
|
89.17€ | 102.80€ | 22.80% | 9 | 111.47€B |
| 4568 | Daiichi Sankyo Company | Buy |
4
|
¥5.53k | ¥5.24k | 7.58% | 0 | ¥10.60T |
| MRNA | Moderna | Outperform |
16
|
$132.90 | $135.42 | -5.19% | 1 | $50.93B |
| 4502 | Takeda Pharmaceutical Company | Outperform |
5
|
¥4.13k | ¥4.74k | 8.96% | 0 | ¥6.48T |
| BIIB | Biogen | Outperform |
10
|
$230.57 | $299.62 | 25.12% | 13 | $33.57B |
| ALNY | Alnylam Pharmaceuticals Inc | Outperform |
7
|
$149.40 | $245.24 | 45.58% | 7 | $18.90B |
| BAX | Baxter International Inc | Hold |
17
|
$35.25 | $44.86 | 24.82% | 5 | $17.96B |
| BMRN | BioMarin Pharmaceutical | Outperform |
10
|
$77.56 | $111.56 | 42.47% | 5 | $14.62B |
| IONS | Ionis Pharmaceuticals | Outperform |
9
|
$37.31 | $55.60 | 60.81% | 3 | $5.76B |
| DYN | Dyne Therapeutics | Buy |
5
|
$27.68 | $28.13 | 31.86% | 0 | $2.27B |
| DCPH | Deciphera Pharmaceuticals | Hold |
6
|
$25.46 | $23.40 | 2.12% | 4 | $2.19B |
| 4516 | Nippon Shinyaku | Outperform |
18
|
¥3.70k | ¥8.34k | 75.77% | 0 | ¥261.33B |
| WVE | Wave Life Sciences | Outperform |
6
|
$6.26 | $9.21 | 91.69% | 3 | $688.23M |
| STOK | Stoke Therapeutics | Buy |
4
|
$13.90 | $19.33 | 43.88% | 3 | $604.59M |
| ABUS | Arbutus Biopharma | Outperform |
9
|
$2.98 | $6.34 | 83.89% | 0 | $535.96M |
| FULC | Fulcrum Therapeutics | Outperform |
9
|
$7.55 | $10.21 | 92.05% | 7 | $456.83M |
| PYC | PYC Therapeutics | Buy |
8
|
$0.10 | $0.30 | 260.00% | 1 | $294.90M |
| AIM | AIM ImmunoTech | Buy |
0
|
$0.40 | $3.83 | 775.00% | 0 | $21.15M |